Koukourakis, M I <br/><br/>
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jan 1999 
 - 107-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(98)00370-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Brain Neoplasms--immunology<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Combined Modality Therapy<br/>Docetaxel<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Feasibility Studies<br/>Female<br/>Glioblastoma--immunology<br/>Humans<br/>Lung Neoplasms--immunology<br/>Lymphocytes--drug effects<br/>Lymphopenia--etiology<br/>Male<br/>Middle Aged<br/>Neoplasms--immunology<br/>Neutropenia--etiology<br/>Paclitaxel--administration & dosage<br/>Pelvic Neoplasms--immunology<br/>Radiation-Sensitizing Agents--administration & dosage<br/>Radiotherapy--adverse effects<br/>Survival Analysis<br/>Taxoids<br/>Treatment Outcome